🚨 OPTIONS ALERT
$312K in #$EWTX puts expiring Jan 2027 (112 days), swept into the offer. That's 4.8x an average day of put flow in one print.
The biggest EWTX put print so far today.
robinflow.io/t/EWTX/muhbzvp4
$312K in #$EWTX puts expiring Jan 2027 (112 days), swept into the offer. That's 4.8x an average day of put flow in one print.
The biggest EWTX put print so far today.
robinflow.io/t/EWTX/muhbzvp4
September 25, 2026 at 8:00 PM
🚨 OPTIONS ALERT
$312K in #$EWTX puts expiring Jan 2027 (112 days), swept into the offer. That's 4.8x an average day of put flow in one print.
The biggest EWTX put print so far today.
robinflow.io/t/EWTX/muhbzvp4
$312K in #$EWTX puts expiring Jan 2027 (112 days), swept into the offer. That's 4.8x an average day of put flow in one print.
The biggest EWTX put print so far today.
robinflow.io/t/EWTX/muhbzvp4
Congratulations to the best TV of the 21st Century, that's right, the Joel's Antique Booth bit on the May 21st, 2003 episode of Late Night with Conan O'Brien. www.youtube.com/watch?v=ewtx...
Late Night 'Joel's Antique Booth 5/21/03
YouTube video by Bobblehead Conan
www.youtube.com
September 25, 2026 at 2:49 PM
Congratulations to the best TV of the 21st Century, that's right, the Joel's Antique Booth bit on the May 21st, 2003 episode of Late Night with Conan O'Brien. www.youtube.com/watch?v=ewtx...
#EWTX Edgewise Therapeutics Unveils the Differentiated Mechanism of Action (MoA) of its Cardiac Sarcomere Modulator EDG-7500
https://www.stocktitan.net/news/EWTX/edgewise-therapeutics-unveils-the-differentiated-mechanism-of-action-wm7wmuo7qoyg.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/EWTX/edgewise-therapeutics-unveils-the-differentiated-mechanism-of-action-wm7wmuo7qoyg.html?utm_source=stocktitan-bluesky&utm_medium=social
Edgewise Therapeutics Unveils the Differentiated Mechanism of Action (MoA) of its Cardiac Sarcomere Modulator EDG-7500
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
September 22, 2026 at 11:00 AM
#EWTX Edgewise Therapeutics Unveils the Differentiated Mechanism of Action (MoA) of its Cardiac Sarcomere Modulator EDG-7500
https://www.stocktitan.net/news/EWTX/edgewise-therapeutics-unveils-the-differentiated-mechanism-of-action-wm7wmuo7qoyg.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/EWTX/edgewise-therapeutics-unveils-the-differentiated-mechanism-of-action-wm7wmuo7qoyg.html?utm_source=stocktitan-bluesky&utm_medium=social
Edgewise Therapeutics Expands Team with New Inducement Stock Options and RSUs#United_States#Boulder#Cardiovascular#Edgewise_Therapeutics#EWTX
Edgewise Therapeutics Expands Team with New Inducement Stock Options and RSUs
Edgewise Therapeutics announces the granting of stock options and restricted stock units to new employees, enhancing their team to address cardiac health.
third-news.com
September 2, 2026 at 12:24 PM
Edgewise Therapeutics Expands Team with New Inducement Stock Options and RSUs#United_States#Boulder#Cardiovascular#Edgewise_Therapeutics#EWTX
Just In: ( NASDAQ: #EWTX ) Edgewise Therapeutics Announces Upcoming Late-Breaking Science Presentation at the European Society of Cardiology (ESC) Congress 2026
August 25, 2026 at 1:01 AM
🚨 $EWTX
Nofi Michael (Chief Financial Officer) reported special transactions (Non-P/S).
Nofi Michael (Chief Financial Officer) reported special transactions (Non-P/S).
SEC Filing: EWTX
Click to view the official SEC document.
www.sec.gov
August 17, 2026 at 10:43 PM
🚨 $EWTX
Nofi Michael (Chief Financial Officer) reported special transactions (Non-P/S).
Nofi Michael (Chief Financial Officer) reported special transactions (Non-P/S).
🚨 $EWTX
Donovan Joanne M. (CMO) reported special transactions (Non-P/S).
Donovan Joanne M. (CMO) reported special transactions (Non-P/S).
SEC Filing: EWTX
Click to view the official SEC document.
www.sec.gov
August 17, 2026 at 10:42 PM
🚨 $EWTX
Donovan Joanne M. (CMO) reported special transactions (Non-P/S).
Donovan Joanne M. (CMO) reported special transactions (Non-P/S).
🚨 $EWTX
Russell Alan J (Chief Scientific Officer) reported special transactions (Non-P/S).
Russell Alan J (Chief Scientific Officer) reported special transactions (Non-P/S).
SEC Filing: EWTX
Click to view the official SEC document.
www.sec.gov
August 17, 2026 at 10:42 PM
🚨 $EWTX
Russell Alan J (Chief Scientific Officer) reported special transactions (Non-P/S).
Russell Alan J (Chief Scientific Officer) reported special transactions (Non-P/S).
🚨 $EWTX
MOORE JOHN R (General Counsel) reported special transactions (Non-P/S).
MOORE JOHN R (General Counsel) reported special transactions (Non-P/S).
SEC Filing: EWTX
Click to view the official SEC document.
www.sec.gov
August 17, 2026 at 10:41 PM
🚨 $EWTX
MOORE JOHN R (General Counsel) reported special transactions (Non-P/S).
MOORE JOHN R (General Counsel) reported special transactions (Non-P/S).
🚨 $EWTX
Derakhshan Behrad (Chief Business Officer) reported special transactions (Non-P/S).
Derakhshan Behrad (Chief Business Officer) reported special transactions (Non-P/S).
SEC Filing: EWTX
Click to view the official SEC document.
www.sec.gov
August 17, 2026 at 10:40 PM
🚨 $EWTX
Derakhshan Behrad (Chief Business Officer) reported special transactions (Non-P/S).
Derakhshan Behrad (Chief Business Officer) reported special transactions (Non-P/S).
📉 Insider Cluster Sell
6 insiders at Edgewise Therapeutics, Inc. (#$EWTX) sold $1.9M in shares over 7 days.
https://earningsfeed.com/companies/1710072-ewtx-edgewise-therapeutics-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
6 insiders at Edgewise Therapeutics, Inc. (#$EWTX) sold $1.9M in shares over 7 days.
https://earningsfeed.com/companies/1710072-ewtx-edgewise-therapeutics-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
August 15, 2026 at 9:40 PM
📉 Insider Cluster Sell
6 insiders at Edgewise Therapeutics, Inc. (#$EWTX) sold $1.9M in shares over 7 days.
https://earningsfeed.com/companies/1710072-ewtx-edgewise-therapeutics-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
6 insiders at Edgewise Therapeutics, Inc. (#$EWTX) sold $1.9M in shares over 7 days.
https://earningsfeed.com/companies/1710072-ewtx-edgewise-therapeutics-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
🚨 $EWTX
Nofi Michael (Chief Financial Officer) reported special transactions (Non-P/S).
Nofi Michael (Chief Financial Officer) reported special transactions (Non-P/S).
SEC Filing: EWTX
Click to view the official SEC document.
www.sec.gov
August 14, 2026 at 9:07 PM
🚨 $EWTX
Nofi Michael (Chief Financial Officer) reported special transactions (Non-P/S).
Nofi Michael (Chief Financial Officer) reported special transactions (Non-P/S).
🚨 $EWTX
Donovan Joanne M. (CMO) sold 9,441 shares at an average price of $43.7139 per common share. (Date: 2026-08-13)
Donovan Joanne M. (CMO) sold 9,441 shares at an average price of $43.7139 per common share. (Date: 2026-08-13)
SEC Filing: EWTX
Click to view the official SEC document.
www.sec.gov
August 14, 2026 at 9:06 PM
🚨 $EWTX
Donovan Joanne M. (CMO) sold 9,441 shares at an average price of $43.7139 per common share. (Date: 2026-08-13)
Donovan Joanne M. (CMO) sold 9,441 shares at an average price of $43.7139 per common share. (Date: 2026-08-13)
🚨 $EWTX
Russell Alan J (Chief Scientific Officer) sold 5,901 shares at an average price of $43.7286 per common share. (Date: 2026-08-12)
Russell Alan J (Chief Scientific Officer) sold 5,901 shares at an average price of $43.7286 per common share. (Date: 2026-08-12)
SEC Filing: EWTX
Click to view the official SEC document.
www.sec.gov
August 14, 2026 at 9:06 PM
🚨 $EWTX
Russell Alan J (Chief Scientific Officer) sold 5,901 shares at an average price of $43.7286 per common share. (Date: 2026-08-12)
Russell Alan J (Chief Scientific Officer) sold 5,901 shares at an average price of $43.7286 per common share. (Date: 2026-08-12)
🚨 $EWTX
MOORE JOHN R (General Counsel) sold 5,016 shares at an average price of $43.8243 per common share. (Date: 2026-08-12)
MOORE JOHN R (General Counsel) sold 5,016 shares at an average price of $43.8243 per common share. (Date: 2026-08-12)
SEC Filing: EWTX
Click to view the official SEC document.
www.sec.gov
August 14, 2026 at 9:05 PM
🚨 $EWTX
MOORE JOHN R (General Counsel) sold 5,016 shares at an average price of $43.8243 per common share. (Date: 2026-08-12)
MOORE JOHN R (General Counsel) sold 5,016 shares at an average price of $43.8243 per common share. (Date: 2026-08-12)
🚨 $EWTX
Derakhshan Behrad (Chief Business Officer) sold 5,100 shares at an average price of $43.8086 per common share. (Date: 2026-08-12)
Derakhshan Behrad (Chief Business Officer) sold 5,100 shares at an average price of $43.8086 per common share. (Date: 2026-08-12)
SEC Filing: EWTX
Click to view the official SEC document.
www.sec.gov
August 14, 2026 at 9:05 PM
🚨 $EWTX
Derakhshan Behrad (Chief Business Officer) sold 5,100 shares at an average price of $43.8086 per common share. (Date: 2026-08-12)
Derakhshan Behrad (Chief Business Officer) sold 5,100 shares at an average price of $43.8086 per common share. (Date: 2026-08-12)
🚨 $EWTX
KOCH KEVIN (President and CEO) sold 17,971 shares at an average price of $43.6838 per common share. (Date: 2026-08-12)
KOCH KEVIN (President and CEO) sold 17,971 shares at an average price of $43.6838 per common share. (Date: 2026-08-12)
SEC Filing: EWTX
Click to view the official SEC document.
www.sec.gov
August 14, 2026 at 9:05 PM
🚨 $EWTX
KOCH KEVIN (President and CEO) sold 17,971 shares at an average price of $43.6838 per common share. (Date: 2026-08-12)
KOCH KEVIN (President and CEO) sold 17,971 shares at an average price of $43.6838 per common share. (Date: 2026-08-12)
🚨 $EWTX
JOANNE DONOVAN, a Officer, filed a notice of intent to sell 2,919 shares of common stock, valued at approximately $127,151.64, on 08/13/2026.
JOANNE DONOVAN, a Officer, filed a notice of intent to sell 2,919 shares of common stock, valued at approximately $127,151.64, on 08/13/2026.
SEC Filing: EWTX
Click to view the official SEC document.
www.sec.gov
August 13, 2026 at 8:52 PM
🚨 $EWTX
JOANNE DONOVAN, a Officer, filed a notice of intent to sell 2,919 shares of common stock, valued at approximately $127,151.64, on 08/13/2026.
JOANNE DONOVAN, a Officer, filed a notice of intent to sell 2,919 shares of common stock, valued at approximately $127,151.64, on 08/13/2026.
$XBI-1 $LITE-1 $SOUN-1 $AMJB-1 $QCOM-1 $AKAM-1 $T-1 $PDLB-1 $IHI-1 $PNNT-1 $MATX-1 $XIFR-1 $OUST-1 $MSTZ-1 $DFH-1 $GLXY-1 $AAPU-1 $EWTX-1 $NB-1 $HNGE-1 $SNXX-1 $MSTR-1 $CERT-1 $VST-1 $MCHP-1 $NUE-1 $LLY-1 $ARAY-1 $POWW-1 $COR-1 $TTMI-1 $TSCO-1 $CELZ-1
August 10, 2026 at 8:15 PM
$XBI-1 $LITE-1 $SOUN-1 $AMJB-1 $QCOM-1 $AKAM-1 $T-1 $PDLB-1 $IHI-1 $PNNT-1 $MATX-1 $XIFR-1 $OUST-1 $MSTZ-1 $DFH-1 $GLXY-1 $AAPU-1 $EWTX-1 $NB-1 $HNGE-1 $SNXX-1 $MSTR-1 $CERT-1 $VST-1 $MCHP-1 $NUE-1 $LLY-1 $ARAY-1 $POWW-1 $COR-1 $TTMI-1 $TSCO-1 $CELZ-1
Edgewise Therapeutics ($EWTX) reported EPS of -0.53 missing estimate of -0.48 for Q2 2026. Revenue 0.0
https://fundspec.ai
Don't just watch EWTX move, predict it! Build your own custom AI trading models for EWTX today by downloading the FundSpec App on the AppStore or PlayStore!
https://fundspec.ai
Don't just watch EWTX move, predict it! Build your own custom AI trading models for EWTX today by downloading the FundSpec App on the AppStore or PlayStore!
August 6, 2026 at 12:45 PM
Edgewise Therapeutics ($EWTX) reported EPS of -0.53 missing estimate of -0.48 for Q2 2026. Revenue 0.0
https://fundspec.ai
Don't just watch EWTX move, predict it! Build your own custom AI trading models for EWTX today by downloading the FundSpec App on the AppStore or PlayStore!
https://fundspec.ai
Don't just watch EWTX move, predict it! Build your own custom AI trading models for EWTX today by downloading the FundSpec App on the AppStore or PlayStore!
Edgewise Therapeutics Secures $2B Pro Forma Cash Position After Transformative Asset Sale https://signalbloom.ai/news/EWTX/edgewise-therapeutics-secures-2b-pro-forma-cash-position-after-transformative-asset-sale $EWTX #Earnings via @signalbloom.ai
August 6, 2026 at 12:08 PM
Edgewise Therapeutics Secures $2B Pro Forma Cash Position After Transformative Asset Sale https://signalbloom.ai/news/EWTX/edgewise-therapeutics-secures-2b-pro-forma-cash-position-after-transformative-asset-sale $EWTX #Earnings via @signalbloom.ai
🚨 $EWTX
On August 6, 2026, Edgewise Therapeutics, Inc. issued a press release announcing its financial results for the second quarter ended June 30, 2026. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
On August 6, 2026, Edgewise Therapeutics, Inc. issued a press release announcing its financial results for the second quarter ended June 30, 2026. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
SEC Filing: EWTX
Click to view the official SEC document.
www.sec.gov
August 6, 2026 at 12:06 PM
🚨 $EWTX
On August 6, 2026, Edgewise Therapeutics, Inc. issued a press release announcing its financial results for the second quarter ended June 30, 2026. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
On August 6, 2026, Edgewise Therapeutics, Inc. issued a press release announcing its financial results for the second quarter ended June 30, 2026. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
#EWTX just printed a fresh $45 Sept call block. 3,000 contracts and only 1 contract of OI behind it.
↗️ Flow: $1.86M calls vs $0 puts
↗️ Price: 44.78 above EMA21/50/200
➡️ Level: $45.03 is the line
↗️ Flow: $1.86M calls vs $0 puts
↗️ Price: 44.78 above EMA21/50/200
➡️ Level: $45.03 is the line
August 5, 2026 at 3:22 PM
#EWTX just printed a fresh $45 Sept call block. 3,000 contracts and only 1 contract of OI behind it.
↗️ Flow: $1.86M calls vs $0 puts
↗️ Price: 44.78 above EMA21/50/200
➡️ Level: $45.03 is the line
↗️ Flow: $1.86M calls vs $0 puts
↗️ Price: 44.78 above EMA21/50/200
➡️ Level: $45.03 is the line
🚨 $EWTX
ROOT JONATHAN D (Insider) reported special transactions (Non-P/S).
ROOT JONATHAN D (Insider) reported special transactions (Non-P/S).
SEC Filing: EWTX
Click to view the official SEC document.
www.sec.gov
July 17, 2026 at 8:58 PM
🚨 $EWTX
ROOT JONATHAN D (Insider) reported special transactions (Non-P/S).
ROOT JONATHAN D (Insider) reported special transactions (Non-P/S).